LM, V., L, C., T, M., O, F., X, M., B, C., . . . JC, Á. (2015). Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumab. Annals of neurology, 77(3), 447. https://doi.org/10.1002/ana.24345
Chicago Style (17th ed.) CitationLM, Villar, et al. "Lipid-specific Immunoglobulin M Bands in Cerebrospinal Fluid Are Associated with a Reduced Risk of Developing Progressive Multifocal Leukoencephalopathy During Treatment with Natalizumab." Annals of Neurology 77, no. 3 (2015): 447. https://doi.org/10.1002/ana.24345.
MLA (9th ed.) CitationLM, Villar, et al. "Lipid-specific Immunoglobulin M Bands in Cerebrospinal Fluid Are Associated with a Reduced Risk of Developing Progressive Multifocal Leukoencephalopathy During Treatment with Natalizumab." Annals of Neurology, vol. 77, no. 3, 2015, p. 447, https://doi.org/10.1002/ana.24345.